Search

everythinglearnresearchcommunity

for

Search:↓

Trichoscopy is useful for diagnosing and monitoring alopecia areata treatment.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

Oxidative stress may contribute to hair loss in alopecia areata and antioxidants could potentially help as a treatment.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Skin symptoms are important for diagnosing infections in children.

Trichoscopy helps diagnose and assess the severity of two types of hair loss diseases, androgenetic alopecia and alopecia areata.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Both mouse and rat models are effective for testing alopecia areata treatments.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Alopecia areata involves immune response and gene changes affecting hair loss.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

There's a significant link between the severity of Seborrheic Dermatitis and the pattern of hair loss in people with a family history of hair loss.

People with alopecia areata, a skin disease, generally have a poor quality of life, especially if more of their scalp is affected.

The same genetic mutation in Sjögren-Larsson syndrome can lead to different levels of severity, suggesting other factors influence the symptoms.

A 70-year-old woman with bronchiectasis developed a rare immune disease due to a bacterial infection, requiring a difficult balance of treatments.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Men with early-onset hair loss have more heart disease risk factors.

COVID-19 may affect male fertility and women might have better outcomes due to hormonal and immune differences.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Early detection and treatment of folliculitis keloidalis can prevent disease progression.

Insulin resistance may contribute to various skin diseases and treating it could improve skin health and prevent more serious conditions.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Certain daily habits like stress, diet, and sleep can affect the severity of hair loss in alopecia areata.